Pharmosa Biopharm Inc. (TPEX:6875)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
52.20
+0.90 (1.75%)
Apr 2, 2025, 1:30 PM CST
-34.75%
Market Cap 6.34B
Revenue (ttm) 167.57M
Net Income (ttm) -166.65M
Shares Out 129.09M
EPS (ttm) -1.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 62,115
Average Volume 83,225
Open 51.60
Previous Close 51.30
Day's Range 51.20 - 52.20
52-Week Range 48.25 - 83.70
Beta 0.58
RSI 29.52
Earnings Date May 15, 2025

About Pharmosa Biopharm

Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, T... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6875
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.